1,25-Dihydroxyvitamin D-mediated hypercalcemia in a renal transplant recipient

Mayo Clinic Proceedings

Volumn 71, Issue 1, 1996, Pages 32-36

  Golconda, Muralikrishna S ^a   Larson, Tlmothy S ^a   Külb, Llsa G ^a   Kumar, Rajiv ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; KIDNEY TRANSPLANTATION; LYMPHOMA; POSTOPERATIVE COMPLICATION; VITAMIN BLOOD LEVEL;

EID: 0030033660     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/71.1.32     Document Type: Article

References (25)

1. McPhaul JJ, Mclntosh DA, Hammond WS, Park OK. Autonomous secondary (renal) parathyroid hyperplasia. N EnglJMed 1964; 271:1342-1345
2. Julian BA, Quarles LD, Niemann KM. Musculoskeletal complications after renal transplantation: pathogenesis and treatment. Am J Kidney Dis 1992; 19:99-120
3. Alfrey AC, Jenkins D, Groth CG, Schorr WS, Gecelter L, Ogden DA. Resolution of hyperparathyroidism, renal osteodystrophy and metastatic calcification after renal Homotransplantation. N Engl J Med 1968; 279:13491356
4. Barbour GL, Coburn JW, Slatopolsky E, Norman AW, Horst RL. Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D. N Engl JMed 1981; 305:440-443
5. Gkonos PJ, London R, Hendler ED. Hypercalcemia and elevated 1,25-dihydroxyvitamin D levels in a patient with end-stage renal disease and active tuberculosis. N Engl J Med 1984; 311:1683-1685
6. Kantarjian HM, Saad MF, Estey EH, Sellin RV, Samaan NA. Hypercalcemia in disseminated candidiasis. Am J Med 1983; 74:721-724
7. Seymour JF, Gagel RF. Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin's disease and nonHodgkin's lymphomas. Blood 1993; 82:1383-1394
8. Klee GG, Preissner CM, Schryver PG, Taylor RL, Kao PC. Multisite immunochemiluminometric assay for simultaneously measuring whole-molecule and amino-terminal fragments of human parathyrin. Clin Chem 1992; 38:628635
9. Kao PC. Klee GG, Taylor RL, Heath H III. Parathyroid hormone-related peptide in plasma of patients with hypercalcemia and malignant lesions. Mayo Clin Proc 1990; 65:1399-1407
10. Pletka PG, Strom TB, Hampers CL, Griffiths H, Wilson RE. Bernstein DS, et al. Secondary hyperparathyroidism in human kidney transplant recipients. Nephron 1976; 17:371381
11. Mclntosh DA, Peterson EW, McPhaul JJ Jr. Autonomy of parathyroid function after renal homotransplantation. Ann Intern Med 1966; 65:900-907
12. Conceicao SC, Wilkinson R, Feest TG, Owen JP, Dewar J, Kerr DN. Hypercalcemia following renal transplantation: causes and consequences. Clin Nephrol 1981; 16:235244
13. Seymour JF, Gagel RF, Hagemeister FB, Dimopoulos MA, Cabanillas F. Calcitriol production in hypercalcémie and normocalcemic patients with non-Hodgkin lymphoma. Ann Intern Med 1994; 121:633-640
14. Penn I, Hammond W, Brettschneider L, Starzl TE. Malignant lymphomas in transplantation patients. Transplant Proc 1969; 1:106-112
15. Penn I. Cancers complicating organ transplantation [editorial]. NEnglJMed 1990; 323:1767-1769
16. Hanto DW, Frizzera G, Gajl-Peczalska KJ, Simmons RL. Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation 1985; 39:461-472
17. Wilkinson AH, Smith JL, Hunsicker LG, Tobacman J, Kapelanski DP, Johnson M, et al. Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisone. Transplantation 1989; 47:293-296
18. Swinnen LJ, Constanzo-Nordin MR, Fisher SG, O'Sullivan EJ, Johnson MR, Heroux AL, et al. Increased incidence of lymphoproliterative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. NEnglJMed 1990; 323:1723-1728
19. Cockfield SM, Preiksaitis JK, Jewell LD, Parfrey NA. Posttransplant lymphoproliferative disorder in renal allograft recipients: clinical experience and risk factor analysis in a single center. Transplantation 1993; 56:88-96
20. Opelz G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 1993; 342:1514-1516
21. Morrison VA, Dünn DL, Manivel JC, Gajl-Peczalska KJ, Peterson BA. Clinical characteristics of post-transplant lymphoproliferative disorders. Am J Med 1994; 97:14-24
22. Hanto DW, Frizzera G, Gajl-Peczalska KJ, Sakamoto K, Purtilo DT, Balfour HH Jr, et al. Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med 1982; 306:913-918
23. Pirsch JD, Stratta RJ, Sollinger HW, Hafez GR, D'Alessandro AM, Kalayoglu M, et al. Treatment of severe Epstein-Barr virus-induced lymphoproliferative syndrome with ganciclovir: two cases after solid organ transplantation. Am J Med 1989; 86:241-244
24. Shapiro RS, Chauvenet A, McGuire W, Pearson A, Craft AW, McGlave P, et al. Treatment of B-cell lymphoproliferative disorders with Interferon alfa and intravenous gamma globulin [letter]. NEnglJMed 1988; 318:1334
25. Fischer A, Blanche S, Le Bidois J, Bordigoni P, Gamier JL, Niaudet P, et al. Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N Engl J Med 1991; 324:1451-1456